Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Authors
Posts by News Wire ~ 3rd Party Press Release
News Wire ~ 3rd Party Press Release
369 POSTS
0 COMMENTS
Flickr
Instagram
Study: OIT Safe for Preschool-Aged Children with Peanut Allergies
News Wire ~ 3rd Party Press Release
-
2019/04/17
0
High-Tech Tissue Study Reveals Which Cells Drive a Painful Food Allergy
News Wire ~ 3rd Party Press Release
-
2019/04/12
0
Study Shows New Triggers of Rare Food Allergy in Infants
News Wire ~ 3rd Party Press Release
-
2019/04/11
0
Researchers Develop First Functional Targeted Inhibitors of Peanut Allergens
News Wire ~ 3rd Party Press Release
-
2019/04/08
0
Snap Medical Announces EMS-Designed Epinephrine Delivery Kit
News Wire ~ 3rd Party Press Release
-
2019/04/05
0
European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...
News Wire ~ 3rd Party Press Release
-
2019/03/25
0
AAP Clinical Report Highlights Early Introduction of Peanut-Based Foods to Prevent...
News Wire ~ 3rd Party Press Release
-
2019/03/19
0
US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut...
News Wire ~ 3rd Party Press Release
-
2019/03/18
0
State Legislation Would Provide Epinephrine Auto-Injectors at No Cost to Patients
News Wire ~ 3rd Party Press Release
-
2019/03/18
0
FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents
News Wire ~ 3rd Party Press Release
-
2019/03/12
0
1
...
28
29
30
...
37
Page 29 of 37